インスリンペンの世界市場

Report Highlights

This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.

Summary:

The global insulin pen market was valued at $REDACTED billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED%, reaching $REDACTED billion by the end of 2028. Growth in this market is fueled by the rising prevalence of diabetes worldwide. As lifestyles change and obesity rates increase, so does the incidence of type 2 diabetes. Additionally, type 1 diabetes rates continue to rise, and both types require insulin for management.

In 2022, the reusable insulin pen segment held the highest market share at about REDACTED%, followed by disposable pens at REDACTED%.

Reasons for Doing This Study:

The market for insulin delivery systems is a crucial segment in healthcare, pivotal in addressing diabetes, a chronic ailment affecting millions worldwide. These systems encompass a broad array of tools and techniques to simplify the administration of insulin, a hormone vital for regulating glucose levels in individuals with diabetes. Over time, these systems have undergone significant advancements, providing diabetic individuals with more user-friendly and effective methods to manage their health.

Integral components of this market are insulin pens, pumps, syringes, and patches, each offering distinct advantages and functionalities tailored to the diverse requirements of diabetes patients.

Insulin pens are a shining example of innovation in diabetes treatment, transforming the day-to-day management of this chronic disease. Insulin pens, designed to be user-friendly and portable, have become essential tools for millions worldwide who rely on insulin therapy. These pens provide a practical, discreet, and accurate method of delivering insulin, allowing people with diabetes to administer exact amounts effortlessly and enabling them to live more flexible and balanced lives. Insulin pens have improved in form, functionality, and compatibility since their beginnings, establishing a new standard in diabetes care and improving the quality of life for individuals with the disease.

Report Scope:

This report thoroughly examines the worldwide market size of global insulin pen delivery technology, enhancing its appeal to stakeholders and readers alike. Current and historical market revenues are estimated based on the type, duration, end user and region.

Report Synopsis

Report Includes:

• An overview of the global market for insulin pen
• Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Evaluation of the current market size and revenue growth prospects specific to insulin pen, accompanied by a comprehensive market share analysis categorized by type, onset time, end user, and geographical region
• A look at the innovations, technological advancements, and the launch of novel products from market players
• Detailed analysis of the regulatory framework and policies and product pipeline of the industry, and discussion on ESG challenges and ESG practices in the insulin pen market
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
• Comprehensive company profiles of the leading players of the industry

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Secondary Research
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Report Highlights
Chapter 3 Market Overview and Definitions
Overview
Diabetes
Type 1 Diabetes
Type 2 Diabetes
Role of Insulin
Diabetes Treatment
Market Dynamics
Market Drivers
Market Restrains
Market Opportunities
Market Challenges
Chapter 4 Market Breakdown by Region
Market Overview and Discussion
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World
Chapter 5 Market Breakdown by Onset Time
Market Overview and Discussion
Long-Acting Insulin
Rapid-Acting Insulin
Intermediate-Acting Insulin
Short-Acting Insulin
Market Size and Forecast
Long-Acting Insulin Pens
Intermediate-Acting Insulin Pens
Short-Acting Insulin Pens
Rapid-Acting Insulin Pens
Chapter 6 Market Breakdown by End User
Market Overview
Hospitals
Pharmacies
Market Size and Forecast
Global Insulin Pen End-Users Market
North American End-User Market
European End-User Market
Asia-Pacific End-User Market
Rest of the World End-User Market
Chapter 7 ESG Development
Introduction
Environmental
Social
Governance
Case Study
Novo Nordisk A/S
Concluding Remarks from BCC
Chapter 8 Competitive Landscape
Overview and Industry Scenario
Company Shares
Recent Key Developments
Chapter 9 Company Profiles
ASTRAZENECA
BIOCON
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
ELI LILLY AND CO.
JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
SANOFI
VIATRIS INC.
Chapter 10 Appendix: Acronyms
List of Acronyms

List of Tables
Summary Table : Global Market for Insulin Pens, by Type, Through 2028
Table 1 : Global Insulin Pens Market Drivers
Table 2 : Global Insulin Pens Market Restraints
Table 3 : Global Insulin Pens Market Challenges
Table 4 : Global Market for Insulin Pens, by Region, Through 2028
Table 5 : North American Market for Insulin Pens, by Type, Through 2028
Table 6 : European Market for Insulin Pens, by Type, Through 2028
Table 7 : Asia-Pacific Market for Insulin Pens, by Type, Through 2028
Table 8 : Rest of the World Market for Insulin Pens, by Type, Through 2028
Table 9 : Insulin Type and Features
Table 10 : Leading Insulin Products and Their Types
Table 11 : Global Market for Insulin Pens, by Onset Time, Through 2028
Table 12 : Global Market for Long-Acting Insulin Pens, by Region, Through 2028
Table 13 : Global Market for Intermediate-Acting Insulin Pens, by Region, Through 2028
Table 14 : Global Market for Short- Acting Insulin Pens, by Region, Through 2028
Table 15 : Global Market for Rapid-Acting Insulin Pens, by Region, Through 2028
Table 16 : Global Market for Insulin Pens for Hospitals, by Region, Through 2028
Table 17 : Global Market for Insulin Pens for Pharmacies, by Region, Through 2028
Table 18 : North American Market for Insulin Pens, by End User, Through 2028
Table 19 : European Market for Insulin Pens, by End User, Through 2028
Table 20 : Asia-Pacific Market for Insulin Pens, by End User, Through 2028
Table 21 : Rest of the World Market for Insulin Pens, by End User, Through 2028
Table 22 : Top Pharma Companies’ ESG Risk Ratings
Table 23 : Novo Nordisk A/S: Key Environmental Performance Indicators, 2020–2022
Table 24 : Novo Nordisk A/S: Key Social Performance Indicators, 2020–2022
Table 25 : Novo Nordisk A/S: Key Governance Performance Indicators, 2020-2022
Table 26 : Global Market Share of Insulin Pens, by Company, 2022
Table 27 : Global Market Shares of Insulin Pens, by Product, 2022
Table 28 : Global Insulin Market, Product Sales Revenue, 2020–2022
Table 29 : Global Diabetes Treatment Market, Selected Recent Key Developments, September 2019–August 2022
Table 30 : AstraZeneca: Company Snapshot
Table 31 : AstraZeneca: Diabetology Product Information
Table 32 : AstraZeneca: Revenue, 2020-2022
Table 33 : AstraZeneca: Recent Key Developments, 2021–2023
Table 34 : Biocon: Company Snapshot
Table 35 : Biocon: Diabetology Product Information
Table 36 : Biocon: Revenue, 2020–2022
Table 37 : Biocon: Key Developments, 2021–2023
Table 38 : Boehringer Ingelheim International GmbH: Company Snapshot
Table 39 : Boehringer Ingelheim International GmbH: Diabetology Product Information
Table 40 : Boehringer Ingelheim International GmbH: Annual Revenue, 2020–2022
Table 41 : Boehringer Ingelheim International GmbH: Key Developments, 2019–2021
Table 42 : Eli Lilly and Co.: Company Snapshot
Table 43 : Eli Lilly and Co: Diabetology Product Information
Table 44 : Eli Lilly and Co: Annual Revenue, 2020–2022
Table 45 : Eli Lilly and Co: Recent Key Developments, 2020–2022
Table 46 : Johnson & Johnson Services Inc.: Company Snapshot
Table 47 : Johnson & Johnson Services Inc.: Diabetology Product Information
Table 48 : Johnson & Johnson Services Inc.: Annual Revenue, 2020–2022
Table 49 : Merck & Co. Inc.: Company Snapshot
Table 50 : Merck & Co. Inc.: Diabetology Product Information
Table 51 : Merck & Co. Inc.: Financials, 2020–2022
Table 52 : Merck & Co. Inc.: Key Developments, 2021
Table 53 : Novartis AG: Company Snapshot
Table 54 : Novartis AG: Diabetology Product Information
Table 55 : Novartis AG: Financials, 2020–2022
Table 56 : Novartis AG: Key Developments, 2023
Table 57 : Novo Nordisk A/S: Company Snapshot
Table 58 : Novo Nordisk A/S: Diabetology Product Information
Table 59 : Novo Nordisk A/S: Revenue, 2020–2022
Table 60 : Novo Nordisk A/S: Recent Developments, 2019-2022
Table 61 : Sanofi: Company Snapshot
Table 62 : Sanofi: Business Segment
Table 63 : Sanofi: Diabetology Product Information
Table 64 : Sanofi: Annual Revenue, 2020–2022
Table 65 : Sanofi: Key Developments, 2021–2023
Table 66 : Viatris Inc.: Company Snapshot
Table 67 : Viatris Inc.: Annual Revenue, 2020-2022
Table 68 : Viatris Inc.: Diabetology Product Information
Table 69 : Major Acronyms Used in This Report

List of Figures
Summary Figure A : Global Market for Insulin Pens, by Type, 2020-2028
Summary Figure B : Global Market Shares of Insulin Pens, by Type, 2022
Figure 1 : Market Dynamics for the Global Insulin Pens Market
Figure 2 : Global Market Shares of Insulin Pens, by Region, 2022
Figure 3 : North American Market Shares of Insulin Pens, by Type, 2022
Figure 4 : European Market Shares of Insulin Pens, by Type, 2022
Figure 5 : Asia-Pacific Market Shares of Insulin Pens, by Type, 2022
Figure 6 : Rest of the World Market Shares of Insulin Pens, by Type, 2022
Figure 7 : Global Market Shares of Insulin Pens, by Onset Time, 2022
Figure 8 : Global Market Shares of Long-Acting Insulin Pens, by Region, 2022
Figure 9 : Global Market Shares of Intermediate-Acting Insulin Pens, by Region, 2022
Figure 10 : Global Market Shares of Short-Acting Insulin Pens, by Region, 2022
Figure 11 : Global Market Shares of Rapid-Acting Insulin Pens, by Region, 2022
Figure 12 : North American Market Shares for Insulin Pens, by End User, 2022
Figure 13 : European Market Shares for Insulin Pens, by End User, 2022
Figure 14 : Asia-Pacific Market Shares for Insulin Pens, by End User, 2022
Figure 15 : Rest of the World Market Shares for Insulin Pens, by End User, 2022
Figure 16 : Global Market Shares of Insulin Pens, by Company, 2022
Figure 17 : Global Market Shares of Insulin Pens, by Product, 2022
Figure 18 : Global Insulin Market, by Product, Sales Revenue, 2022
Figure 19 : AstraZeneca: Revenue Share, by Country, 2022
Figure 20 : Merck & Co. Inc.: Annual Revenue, by Segment, 2020–2022
Figure 21 : Novartis AG: Innovative Medicine, Market Share, by Region, 2022
Figure 22 : Novartis AG: Market Share, by Region, 2022
Figure 23 : Sanofi: Annual Revenue, by Region, 2022
Figure 24 : Sanofi: Revenue, by Segment, 2022
Figure 25 : Viatris Inc.: Sales Share, by Region, 2022